<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39359495</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6973</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Infection and drug resistance</Title><ISOAbbreviation>Infect Drug Resist</ISOAbbreviation></Journal><ArticleTitle>The Impact of Infection Control Policies on Hospital Acquired Infections by MDROs from 2016 to 2023.</ArticleTitle><Pagination><StartPage>4213</StartPage><EndPage>4221</EndPage><MedlinePgn>4213-4221</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IDR.S481412</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Hospital-acquired infections (HAIs) caused by multidrug-resistant organisms (MDROs) pose a significant challenge to healthcare systems. The present study aimed to evaluate the impact of the infection policy to COVID-19 on the incidence of HAIs caused by MDROs.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted an eight-years retrospective analysis at a hospital in Shanghai, China. Bloodstream, sputum, and urinary tract cultures of MDROs obtained 48h after admission were collected monthly from January 2016 to Dec 2023. Occupied bed days (OBDs) were used to generate monthly HAI incidences per 10,000 OBDs. The study period was divided into pre-control, in-control, and post-control cohorts, in January 2020 and January 2022. The incidence was compared using interrupted time-series regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In total, 6763 MDRO cultures were identified, comprising 1058 bloodstream, 4581 sputum, and 1124 urine cultures derived from 4549 patients. The incidence rates of all HAIs were 8.68 per 10,000 OBDs in the pre-control cohort, 9.76 per 10,000 OBDs in the in-control cohort and 12.58 per 10,000 OBDs in the post-control cohorts, respectively. A downward trend in the incidence of HAI was observed in the post-control cohort (p&lt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This study demonstrates that while the COVID-19 pandemic poses a significant challenge to infection control within hospitals, it provides a unique opportunity to enhance infection control measures and evaluate their effectiveness. In addition, these findings highlight the need for more targeted prevention and control strategies against different pathogens in future epidemics.</AbstractText><CopyrightInformation>© 2024 Wang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Yichen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Hospital Infection Management, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Yibo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Hospital Infection Management, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Hospital Infection Management, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Hospital Infection Management, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Dake</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Hospital Infection Management, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yumin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Hospital Infection Management, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Infect Drug Resist</MedlineTA><NlmUniqueID>101550216</NlmUniqueID><ISSNLinking>1178-6973</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">hospital required infection</Keyword><Keyword MajorTopicYN="N">infection control</Keyword><Keyword MajorTopicYN="N">multidrug-resistant organism</Keyword><Keyword MajorTopicYN="N">policy</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39359495</ArticleId><ArticleId IdType="pmc">PMC11446211</ArticleId><ArticleId IdType="doi">10.2147/IDR.S481412</ArticleId><ArticleId IdType="pii">481412</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang Y, Wang Y, Sheng Z, et al. Incidence rate, pathogens and economic burden of catheter-related bloodstream infection: a single-center, retrospective case-control study. Infect Drug Resist. 2023;16:3551–3560. doi:10.2147/IDR.S406681</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S406681</ArticleId><ArticleId IdType="pmc">PMC10256568</ArticleId><ArticleId IdType="pubmed">37305736</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcántar-Curiel MD, Huerta-Cedeño M, Jarillo-Quijada MD, et al. Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic. PeerJ. 2023;11:e15007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10066687</ArticleId><ArticleId IdType="pubmed">37013147</ArticleId></ArticleIdList></Reference><Reference><Citation>Farthing TS, Jolley A, Nickel KB, et al. Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patients. Infect Control Hosp Epidemiol. 2023;44(12):1966–1971. doi:10.1017/ice.2023.83</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2023.83</ArticleId><ArticleId IdType="pmc">PMC10755158</ArticleId><ArticleId IdType="pubmed">37381734</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JJ, Park H, Na SH, Seo YB, Lee J. Trends of antimicrobial susceptibilities and multidrug-resistant colonization rate in patients transferred from long-term care facilities during 2017-2022: a cross-sectional study. BMC Infect Dis. 2024;24(1):235. doi:10.1186/s12879-024-09145-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09145-y</ArticleId><ArticleId IdType="pmc">PMC10882737</ArticleId><ArticleId IdType="pubmed">38383425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemonnier D, Machuel M, Obin O, Outurquin G, Adjidé C, Mullié C. Trends in antibiotic-resistant bacteria isolated from screening clinical samples in a tertiary care hospital over the 2018-2022 Period. Antibiotics. 2023;12(8):1314. doi:10.3390/antibiotics12081314</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12081314</ArticleId><ArticleId IdType="pmc">PMC10451239</ArticleId><ArticleId IdType="pubmed">37627734</ArticleId></ArticleIdList></Reference><Reference><Citation>Jernigan JA, Hatfield KM, Wolford H, et al. Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017. New Engl J Med. 2020;382(14):1309–1319. doi:10.1056/NEJMoa1914433</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1914433</ArticleId><ArticleId IdType="pmc">PMC10961699</ArticleId><ArticleId IdType="pubmed">32242356</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasciana T, Antonelli A, Bianco G, et al. Multicenter study on the prevalence of colonization due to carbapenem-resistant enterobacterales strains before and during the first year of COVID-19, Italy 2018-2020. Front Public Health. 2023;11:1270924. doi:10.3389/fpubh.2023.1270924</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1270924</ArticleId><ArticleId IdType="pmc">PMC10771343</ArticleId><ArticleId IdType="pubmed">38186699</ArticleId></ArticleIdList></Reference><Reference><Citation>Amodio E, Pizzo S, Vella G, et al. Increase of multidrug-resistant bacteria after the COVID-19 pandemic in a major teaching hospital in Sicily (2018-2021). Int J Antimicrob Agents. 2024;63(5):107123. doi:10.1016/j.ijantimicag.2024.107123</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2024.107123</ArticleId><ArticleId IdType="pubmed">38408493</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wu R, Wu M-Y, Zhu G. Changes and predictors of mental health of Chinese university students after the COVID-19 pandemic: a two-year study. J Affective Disorders. 2024;352:1–9. doi:10.1016/j.jad.2024.02.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2024.02.037</ArticleId><ArticleId IdType="pubmed">38355054</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Wu K, Chen H, et al. The impact of the COVID-19 pandemic on nosocomial infections: a retrospective analysis in a tertiary maternal and child healthcare hospital. Front Public Health. 2023;11:1132323. doi:10.3389/fpubh.2023.1132323</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1132323</ArticleId><ArticleId IdType="pmc">PMC10151874</ArticleId><ArticleId IdType="pubmed">37143971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wayne P. Clinical and laboratory standards institute (CLSI) performance standards for antimicrobial susceptibility testing. Inform Suppl; 2018.</Citation></Reference><Reference><Citation>Linden A. Conducting Interrupted Time-series Analysis for Single- and Multiple-group Comparisons. Stata J. 2015;15(2):480–500. doi:10.1177/1536867X1501500208</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X1501500208</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaffer CFBME. ”ACTEST: stata module to perform Cumby-Huizinga general test for autocorrelation in time series”. Statistical Software Components S457668. Boston College Department of Economics; 2013.</Citation></Reference><Reference><Citation>Ismael YH, Pacheco ECHG, Zhen F, et al. Clinical and microbiological profile of health care-associated infections in a tertiary hospital: comparison between a cohort of hospitalized patients during prepandemic and COVID-19 pandemic periods. Am J Infect Control. 2024;52(6):712–718. doi:10.1016/j.ajic.2023.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2023.12.018</ArticleId><ArticleId IdType="pubmed">38181901</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrović K, Škrobo T, Selec K, et al. Healthcare-associated bloodstream infections due to multidrug-resistant Acinetobacter baumannii in COVID-19 intensive care unit: a single-center retrospective study. Microorganisms. 2023;11(3):774. doi:10.3390/microorganisms11030774</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11030774</ArticleId><ArticleId IdType="pmc">PMC10056625</ArticleId><ArticleId IdType="pubmed">36985347</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrianopoulos I, Maniatopoulou T, Lagos N, et al. Acinetobacter baumannii bloodstream infections in the COVID-19 era: a comparative analysis between COVID-19 and non-COVID-19 critically ill patients. Microorganisms. 2023;11(7):1811. doi:10.3390/microorganisms11071811</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11071811</ArticleId><ArticleId IdType="pmc">PMC10383443</ArticleId><ArticleId IdType="pubmed">37512983</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu D, Zhao J, Chang K, Zhuo X, Cao B. ”Superbugs” with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China. Sci Bull. 2023;68(21):2658–2670. doi:10.1016/j.scib.2023.09.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scib.2023.09.040</ArticleId><ArticleId IdType="pubmed">37821268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Liu X, Li W, et al. Epidemiological characteristics and antimicrobial resistance changes of carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii under the COVID-19 outbreak: an interrupted time series analysis in a large teaching hospital. Antibiotics. 2023;12(3):431. doi:10.3390/antibiotics12030431</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12030431</ArticleId><ArticleId IdType="pmc">PMC10044178</ArticleId><ArticleId IdType="pubmed">36978298</ArticleId></ArticleIdList></Reference><Reference><Citation>Papanikolopoulou A, Vini L, Stoupis A, et al. Carbapenem-resistant Klebsiella pneumoniae bacteremia: counterbalance between the endemic load and the infection control program in a hospital. Acta Microbiol Hellenica. 2024;69(2):81–92. doi:10.3390/amh69020009</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/amh69020009</ArticleId></ArticleIdList></Reference><Reference><Citation>Bologna E, Licari LC, Manfredi C, et al. Carbapenem-resistant Enterobacteriaceae in urinary tract infections: from biological insights to emerging therapeutic alternatives. Medicina. 2024;60(2):214. doi:10.3390/medicina60020214</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina60020214</ArticleId><ArticleId IdType="pmc">PMC10889937</ArticleId><ArticleId IdType="pubmed">38399502</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen J, Menezes GA, Abdulrazzaq NM, Moubareck CA, Senok A, Everett DB. Evolving trends among pseudomonas aeruginosa: a 12-year retrospective study from the United Arab Emirates. Front Public Health. 2023;11:1243973. doi:10.3389/fpubh.2023.1243973</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1243973</ArticleId><ArticleId IdType="pmc">PMC10721971</ArticleId><ArticleId IdType="pubmed">38106909</ArticleId></ArticleIdList></Reference><Reference><Citation>Abubakar U, Al-Anazi M, Alanazi Z, Rodríguez-Baño J. Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review. J Infect public Health. 2023;16(3):320–331. doi:10.1016/j.jiph.2022.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.12.022</ArticleId><ArticleId IdType="pmc">PMC9804969</ArticleId><ArticleId IdType="pubmed">36657243</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(Suppl 1):1–55. doi:10.1111/1469-0691.12427</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12427</ArticleId><ArticleId IdType="pubmed">24329732</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill ME, Jaworski M, Harcy V, et al. Cluster of carbapenemase-producing carbapenem-resistant pseudomonas aeruginosa among patients in an adult intensive care unit - Idaho, 2021-2022. MMWR Morb Mortal Wkly Rep. 2023;72(31):844–846. doi:10.15585/mmwr.mm7231a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7231a2</ArticleId><ArticleId IdType="pmc">PMC10414995</ArticleId><ArticleId IdType="pubmed">37535466</ArticleId></ArticleIdList></Reference><Reference><Citation>Plachouras D, Kacelnik O, Rodríguez-Baño J, et al. Revisiting the personal protective equipment components of transmission-based precautions for the prevention of COVID-19 and other respiratory virus infections in healthcare. Euro Surveillance. 2023;28(32): 2200718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10416576</ArticleId><ArticleId IdType="pubmed">37561052</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>